Eli Lilly and Company (ETR:LLY)
746.80
+23.10 (3.19%)
Apr 24, 2025, 5:35 PM CET
Eli Lilly and Company Revenue
In the year 2024, Eli Lilly and Company had annual revenue of $45.04B USD with 32.00% growth. Eli Lilly and Company had revenue of $13.53B in the quarter ending December 31, 2024, with 44.68% growth.
Revenue
$45.04B
Revenue Growth
+32.00%
P/S Ratio
15.06
Revenue / Employee
$958.36K
Employees
47,000
Market Cap
655.21B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Eli Lilly and Company News
- 1 day ago - Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro - The Hill
- 1 day ago - Tech sector soars: The revival of Silicon Valley giants - Forexlive
- 1 day ago - Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug - The Motley Fool
- 1 day ago - Novo: On Track To The Mid $40s While Loosing Market Share To Eli Lilly - Seeking Alpha
- 1 day ago - Stocks making the biggest moves premarket: Boeing, Tesla, BP, Eli Lilly and more - CNBC
- 1 day ago - Direxion's Eli Lilly-Focused Bull And Bear Funds Offer Speculative Alternatives - Benzinga
- 1 day ago - Direxion's Eli Lilly-Focused Bull And Bear Funds Offer Speculative Alternatives - Benzinga
- 1 day ago - Is Eli Lilly Stock Going to $900? 1 Wall Street Analyst Thinks So. - The Motley Fool